Summit Therapeutics
SMMT
SMMT
17 hedge funds and large institutions have $7.6M invested in Summit Therapeutics in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
86% less capital invested
Capital invested by funds: $53.3M → $7.6M (-$45.7M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $45K
Holders
17
Holding in Top 10
–
Calls
–
Puts
$45K
Top Buyers
| 1 | +$69.3K | |
| 2 | +$44K | |
| 3 | +$37K | |
| 4 |
FFW
Fusion Family Wealth
Woodbury,
New York
|
+$25K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$18K |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$1.81M | |
| 3 | -$1.03M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$639K |
| 5 |
Renaissance Technologies
New York
|
-$137K |